Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway
- PMID: 28209511
- DOI: 10.1016/j.bbrc.2017.02.060
Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway
Abstract
Heparanase-1/syndecan-1 axis plays critical roles in tumorigenesis and development. The main mechanism includes heparanase-1 (HPA-1) degrades the heparan sulfate chain of syndecan-1 (SDC-1), and the following shedding of heparan sulfate from tumor cell releases and activates SDC-1 sequestered growth factors. However, the significance of Heparanase-1/syndecan-1 axis and its effects on the microenvironment of lymphatic metastasis in hepatocellular carcinogenesis (HCC) procession have not been reported. Herein, we found that HPA-1 could degrade the heparan sulfate on hepatocarcinoma cell surface. Importantly, HPA-1-induced shedding of heparan sulfate chain from SDC-1 facilitated the release of vascular endothelial growth factor C (VEGF-C) from SDC-1/VEGF-C complex into the medium of hepatocarcinoma cell. Further studies indicated that VEGF-C secretion from hepatocarcinoma cell promoted lymphatic endothelial cell growth through activating extracellular signal-regulated kinase (ERK) signaling. Taken together, this study reveals a novel existence of Heparanase-1/syndecan-1 axis in hepatocarcinoma cell and its roles in the cross-talking with the microenvironment of lymphatic metastasis.
Keywords: Heparan sulfate; Heparanase-1; Syndecan-1; VEGF-C.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.Blood. 2010 Mar 25;115(12):2449-57. doi: 10.1182/blood-2009-07-234757. Epub 2010 Jan 22. Blood. 2010. PMID: 20097882 Free PMC article.
-
Heparanase regulates levels of syndecan-1 in the nucleus.PLoS One. 2009;4(3):e4947. doi: 10.1371/journal.pone.0004947. Epub 2009 Mar 23. PLoS One. 2009. PMID: 19305494 Free PMC article.
-
Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.Vascul Pharmacol. 2013 Sep-Oct;59(3-4):112-8. doi: 10.1016/j.vph.2013.08.001. Epub 2013 Aug 11. Vascul Pharmacol. 2013. PMID: 23939434
-
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.FEBS J. 2013 May;280(10):2294-306. doi: 10.1111/febs.12168. Epub 2013 Mar 4. FEBS J. 2013. PMID: 23374281 Free PMC article. Review.
-
Mechanisms of heparanase inhibitors in cancer therapy.Exp Hematol. 2016 Nov;44(11):1002-1012. doi: 10.1016/j.exphem.2016.08.006. Epub 2016 Aug 26. Exp Hematol. 2016. PMID: 27576132 Free PMC article. Review.
Cited by
-
Prognostic Role of the Intrahepatic Lymphatic System in Liver Cancer.Cancers (Basel). 2023 Apr 4;15(7):2142. doi: 10.3390/cancers15072142. Cancers (Basel). 2023. PMID: 37046803 Free PMC article. Review.
-
A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression.Korean J Pain. 2023 Jan 1;36(1):60-71. doi: 10.3344/kjp.22277. Epub 2022 Dec 20. Korean J Pain. 2023. PMID: 36536517 Free PMC article.
-
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.Int J Mol Sci. 2020 Sep 9;21(18):6588. doi: 10.3390/ijms21186588. Int J Mol Sci. 2020. PMID: 32916872 Free PMC article. Review.
-
Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans.Bioengineering (Basel). 2022 Oct 18;9(10):566. doi: 10.3390/bioengineering9100566. Bioengineering (Basel). 2022. PMID: 36290535 Free PMC article.
-
Crosstalk between tumor cells and lymphocytes modulates heparanase expression.J Transl Med. 2019 Mar 29;17(1):103. doi: 10.1186/s12967-019-1853-z. J Transl Med. 2019. PMID: 30922347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous